Singapūras - anglų - HSA (Health Sciences Authority)

orion pharma (sg) pte. ltd. - carbidopa monohydrate eqv carbidopa; entacapone; levodopa - tablet, film coated - 13.5 mg (corresponds to 12.5 mg carbidopa) - carbidopa monohydrate eqv carbidopa 12.5 mg; entacapone 200 mg; levodopa 50 mg

Singapūras - anglų - HSA (Health Sciences Authority)

orion pharma (sg) pte. ltd. - budesonide - powder, metered - 200 mcg/dose - budesonide 200 mcg/dose

Australija - anglų - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - diazepam, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: ethanol; propylene glycol; glycerol; citric acid; sodium citrate dihydrate; purified water; flavour - indications as at 30 september 2003: diazepam is indicated in the management of anxiety disorders and for the short term relief of the symptoms of anxiety. diazepam is a useful adjunct for the relief of reflux muscle spasm due to local trauma (injury, inflammation) to muscles, bones and joints. it is also indicated in the management of cerebral spasiticity due to upper motor neuron lesions such as cerebral palsy and paraplegia, and spasticity in athetosis and stiff man syndrome. in acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - chloral hydrate, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sucrose; citric acid; sodium citrate dihydrate; saccharin sodium; glycerol; methyl hydroxybenzoate; ethanol; propylene glycol; purified water; flavour - indications as at 19 september 2003: chloral hydrate mixture is indicated pre-operatively to produce sedation. it is also indicated for short term (not more than 2 weeks) use as a hypnotic to assist in sleep disorders.

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

orion pharma (uk - entacapone - tablet - 200mg

Airija - anglų - HPRA (Health Products Regulatory Authority)

orion corporation - carbidopa monohydrate; levodopa - tablet - levodopa and decarboxylase inhibitor

Airija - anglų - HPRA (Health Products Regulatory Authority)

orion corporation - carbidopa monohydrate; levodopa - tablet - levodopa and decarboxylase inhibitor

Airija - anglų - HPRA (Health Products Regulatory Authority)

orion corporation - sugammadex sodium - solution for injection - sugammadex

Australija - anglų - Department of Health (Therapeutic Goods Administration)

orion pharma (aus) pty limited - estradiol, quantity: 1 mg/g - gel - excipient ingredients: purified water; propylene glycol; carbomer 934p; ethanol; trolamine - short-term treatment of climacteric symptoms after natural or surgical menopause. whenever possible the lowest effective dose should be used. review the need for continuation of treatment after 6 months, taking into account the risk-benefit ratio for the individual user at that moment (including cardiovascular disease and breast cancer, see section 5.1 pharmacodynamic properties - clinical trials and section 4.4 special warnings and precautions for use). sandrena should only be continued for as long as the benefit outweighs the risks

Singapūras - anglų - HSA (Health Sciences Authority)

orion pharma (sg) pte. ltd. - dexmedetomidine hydrochloride eqv dexmedetomidine - infusion, solution concentrate - dexmedetomidine hydrochloride eqv dexmedetomidine 100 mcg/ml